# Chapter 2.5 æ–‡çŒ®æ•´åˆæŒ‡å—
## Text Mining and Topic Modeling - æ–°æ–‡çŒ®æ•´åˆæ–¹æ¡ˆ

**åˆ›å»ºæ—¥æœŸ**: 2025-11-06
**ç›®çš„**: æŒ‡å¯¼å°† 15 ç¯‡æ–°æ–‡çŒ®æ•´åˆåˆ° Chapter 2.5 manuscript

---

## ğŸ“‹ æ•´åˆæ¦‚è§ˆ

### æ–°å¢æ–‡çŒ®ç»Ÿè®¡
- **å¾…æ•´åˆæ–‡çŒ®**: 15 ç¯‡é«˜ç›¸å…³æ€§æ–‡çŒ®
- **å¹´ä»½èŒƒå›´**: 2018-2023
- **ä¼˜å…ˆçº§ 1 (å¿…é¡»)**: 3 ç¯‡
- **ä¼˜å…ˆçº§ 2 (å¼ºçƒˆå»ºè®®)**: 3 ç¯‡
- **ä¼˜å…ˆçº§ 3 (å¯é€‰)**: 9 ç¯‡

### æ•´åˆç›®æ ‡
1. âœ… æ›´æ–°æ–‡çŒ®è‡³ 2023 å¹´
2. âœ… å¼ºåŒ–è·¨æ–‡åŒ–/è·¨è¯­è¨€è®ºè¿°ï¼ˆSection 2.5.5ï¼‰
3. âœ… è¡¥å……æ·±åº¦å­¦ä¹  vs. LDA çš„è®¨è®º
4. âœ… å¢åŠ æƒ…æ„Ÿåˆ†æ + ä¸»é¢˜å»ºæ¨¡ç»“åˆæ¡ˆä¾‹
5. âœ… æ‰©å±• LDA åº”ç”¨èŒƒå›´ï¼ˆé¢„æµ‹ã€ç›‘æ§ï¼‰

---

## ğŸ¯ Priority 1: æ ¸å¿ƒæ•´åˆï¼ˆå¿…é¡»åŠ å…¥ï¼‰

### æ•´åˆ 1: Section 2.5.1 - Text Mining Approaches

**æ’å…¥ä½ç½®**: **Section 2.5.1** åœ¨ "**4. Topic Modeling**" éƒ¨åˆ†ä¹‹åï¼Œ"**Why LDA is ideal...**" ä¹‹å‰

**æ–°å¢æ®µè½**:

```markdown
**Recent Methodological Advances**

Text mining methods continue to evolve, particularly in healthcare applications. Sun et al. (2018) provide a comprehensive review of data processing and text mining technologies for electronic medical records (EMR), emphasizing that healthcare textsâ€”characterized by diversity, incompleteness, and redundancyâ€”require rigorous preprocessing before analysis. Named-entity recognition (NER) and relation extraction (RE) form the foundation for advanced text mining applications.

Recent studies demonstrate the value of combining multiple methods. van Buchem et al. (2022) developed the Artificial Intelligence Patient-Reported Experience Measure (AI-PREM), integrating open-ended questionnaires with an NLP pipeline that combines sentiment analysis and topic modeling. Applied to 534 vestibular schwannoma patients, the AI-PREM achieved 90% overlap between automated and manually extracted topics, with sentiment analysis F1 scores of 0.97 for positive and 0.63 for negative texts. The hierarchical visualizationâ€”structured by sentiment per question, topics per sentiment, and original responses per topicâ€”enables healthcare professionals to efficiently prioritize patient experience improvements without being confined to closed-ended survey options.

Shah et al. (2021) similarly demonstrated the power of methodological integration. Analyzing 700,000 UK physician reviews from Iwantgreatcare.org using SentiNet (sentiment analysis) combined with LDA, they distinguished patient satisfaction drivers (hospital processes, physician competence) from dissatisfaction drivers (treatment experience, staff manner), achieving 88% F1-score in classification. These integrated approaches outperform single-method strategies, capturing both thematic structure (via LDA) and affective valence (via sentiment analysis).
```

**æ–°å¢å¼•ç”¨ (3 ç¯‡)**:
1. âœ… Sun et al. (2018) - æ–‡æœ¬æŒ–æ˜ç»¼è¿°
2. âœ… van Buchem et al. (2022) - AI-PREM ç»¼åˆæ–¹æ³•
3. âœ… Shah et al. (2021) - æƒ…æ„Ÿåˆ†æ + LDA

---

### æ•´åˆ 2: Section 2.5.3 - LDA in Healthcare Service Quality Research

**æ’å…¥ä½ç½® A**: **"Existing Applications"** å°èŠ‚ï¼Œåœ¨ "**Arnold et al. (2016)**" ä¹‹å

**æ–°å¢æ®µè½**:

```markdown
**Geletta et al. (2019): LDA for clinical trial termination prediction**
- **Data**: ClinicalTrials.gov repository (structured + unstructured narrative)
- **Method**: LDA extracted 25 topics from trial narrative descriptions; Random Forest prediction combining structured data and LDA topics
- **Finding**: Models incorporating LDA topics (Model 2) significantly outperformed models using structured data alone (Model 1) in predicting trial terminations, with enhanced sensitivity and specificity
- **Contribution**: Validated LDA's predictive utilityâ€”demonstrating that latent topics extracted from unstructured text capture risk factors invisible in structured data. This extends LDA's application beyond descriptive thematic analysis to predictive modeling for clinical decision support

**Altintas et al. (2021): LDA for social media health discussions**
- **Data**: Reddit cancer disease forum posts
- **Method**: LDA with coherence testing and t-SNE visualization for topic relationships
- **Topics identified**: Cancer treatment experiences, patient support, disease progression, side effects management
- **Contribution**: Demonstrated LDA's applicability to informal social media texts (beyond formal reviews), with coherence tests validating topic quality

**Danek et al. (2023): LDA for real-time policy monitoring**
- **Data**: 3,647 Google reviews of six Berlin COVID-19 mass vaccination centers (December 2020-December 2021)
- **Method**: Topic modeling identified five optimal latent topics; keyword extraction (47 salient keywords); sentiment analysis tracked rating changes over time
- **Topics identified**: Organization, friendliness/responsiveness, patient flow/wait time
- **Key findings**: Average ratings declined from 4.7 to 4.1 over one year; "appointment" and "wait" keywords dominated negative reviews
- **Contribution**: Showcased online reviews for **real-time monitoring** of newly established healthcare infrastructures, informing policy adjustments during pandemic response
```

**æ–°å¢å¼•ç”¨ (3 ç¯‡)**:
4. âœ… Geletta et al. (2019) - LDA é¢„æµ‹åº”ç”¨
5. âœ… Altintas et al. (2021) - ç¤¾äº¤åª’ä½“ LDA
6. âœ… Danek et al. (2023) - å®æ—¶æ”¿ç­–ç›‘æ§

**æ’å…¥ä½ç½® B**: **"Synthesis"** æ®µè½ä¿®æ”¹

**åŸæ–‡**:
> Synthesis: LDA successfully discovers interpretable topics in healthcare texts across multiple contexts (reviews, forums, clinical notes). Topics often align with but extend existing theoretical frameworks (e.g., SERVQUAL), validating LDA as a discovery tool.

**ä¿®æ”¹ä¸º**:
> **Synthesis**: LDA successfully discovers interpretable topics in healthcare texts across diverse contextsâ€”physician and hospital reviews (Hao & Zhang, 2016; Wallace et al., 2014), patient forums (Doing-Harris & Zeng-Treitler, 2011; Altintas et al., 2021), clinical notes (Arnold et al., 2016), and clinical trial narratives (Geletta et al., 2019). Topics often align with but extend existing theoretical frameworks (e.g., SERVQUAL), validating LDA as both a discovery and predictive tool. Recent applications demonstrate LDA's utility for real-time policy monitoring (Danek et al., 2023), expanding its role beyond post-hoc analysis to dynamic quality surveillance.

---

### æ•´åˆ 3: Section 2.5.5 - Cross-Cultural Topic Modeling

**æ’å…¥ä½ç½®**: **"Language-Specific Preprocessing"** å°èŠ‚ï¼Œåœ¨ "**Challenge 3: Stemming/Lemmatization**" ä¹‹å

**æ–°å¢æ®µè½**:

```markdown
**Challenge 4: Cross-Linguistic NLP Validation**

Cross-linguistic applications validate NLP methods' robustness across languages. Alhazzani et al. (2023) successfully classified Arabic patient experience comments into 25 categories using deep learning (BiLSTM, BiGRU) and customized BERT models (PX_BERT, AraBERTv02). The domain-adapted PX_BERT, pre-trained on patient experience texts, outperformed general Arabic BERT models, achieving the highest F1-scores. This demonstrates two critical principles for cross-cultural text mining:

1. **Language-specific models are essential**: General-purpose NLP models trained on English (or standard Arabic) underperform compared to domain-adapted, language-specific models.

2. **Preprocessing requirements vary**: Arabic text required specialized tokenization, morphological analysis, and diacritical mark handlingâ€”preprocessing steps unnecessary for English but critical for Arabic NLP accuracy.

Similarly, Yazdani et al. (2023) applied sentiment analysis and topic modeling to Persian-language cancer patient feedback from Tehran University's Cancer Institute. Achieving 89-93% accuracy in sentiment classification across service dimensions, they extracted themes such as "metastasis" (lower sentiment scores) and "affable staff" (higher sentiment scores). Topic-level sentiment analysis revealed that while patients expressed dissatisfaction with appointment booking services, they reported positive sentiments toward chemotherapy care and staff interactions.

**Implication for this study**: These cross-linguistic validations underscore the importance of language-specific preprocessing for Chinese (Traditional) reviews in Taiwan. Standard NLP tools trained on English or Simplified Chinese may not perform optimally. This study employs:
- **Jieba segmentation** with custom medical dictionaries (68 terms) for Traditional Chinese
- **Iteratively refined stopword lists** (84 Chinese stopwords) tailored to hospital review corpora
- **Separate LDA training** for Taiwan and U.S. corpora (rather than forcing translation or multilingual models), ensuring culturally authentic topic discovery
```

**æ–°å¢å¼•ç”¨ (2 ç¯‡)**:
7. âœ… Alhazzani et al. (2023) - è·¨è¯­è¨€ï¼ˆé˜¿æ‹‰ä¼¯è¯­ï¼‰
8. âœ… Yazdani et al. (2023) - è·¨è¯­è¨€ï¼ˆæ³¢æ–¯è¯­ï¼‰

---

## ğŸ¯ Priority 2: é‡è¦è¡¥å……ï¼ˆå¼ºçƒˆå»ºè®®ï¼‰

### æ•´åˆ 4: Section 2.5.1 - Sentiment Analysis è¡¥å……

**æ’å…¥ä½ç½®**: **"2. Sentiment Analysis"** éƒ¨åˆ†ï¼Œåœ¨ "**Limitations**" ä¹‹å

**æ–°å¢æ®µè½**:

```markdown
**Recent Advances in Healthcare Sentiment Analysis**

Recent studies demonstrate improved sentiment analysis accuracy when combined with topic modeling. Yazdani et al. (2023) achieved 89-93% accuracy in detecting cancer patients' sentiments toward general services, healthcare services, and life expectancy using Persian-language free-text comments. By integrating topic modeling, they identified that the "metastasis" topic exhibited lower sentiment scores compared to "affable staff" and "chemotherapy" topics, revealing that sentiment varies not just by document but by thematic content within documents.

Nawab et al. (2020) demonstrated NLP's practical utility in extracting meaningful information from Press Ganey patient feedback surveys. With reimbursement increasingly tied to patient experience metrics (e.g., Hospital Consumer Assessment of Healthcare Providers and Systems - HCAHPS), hospitals leverage NLP for scalable, continuous monitoring beyond periodic structured surveys. This real-world implementation highlights NLP's shift from research tool to clinical operations support.
```

**æ–°å¢å¼•ç”¨ (2 ç¯‡)**:
9. âœ… Yazdani et al. (2023) - æƒ…æ„Ÿåˆ†æå‡†ç¡®ç‡
10. âœ… Nawab et al. (2020) - å®åŠ¡åº”ç”¨

---

### æ•´åˆ 5: Section 2.5.1 - æ·±åº¦å­¦ä¹  vs. LDA å¯¹æ¯”

**æ’å…¥ä½ç½®**: **"4. Topic Modeling"** éƒ¨åˆ†ï¼Œåœ¨ "**This study employs LDA**" ä¹‹å‰

**æ–°å¢æ®µè½**:

```markdown
**Alternative Approaches: Deep Learning for Topic Classification**

While LDA discovers topics unsupervised, supervised deep learning methods offer an alternative when labeled training data is available. Athira et al. (2021) applied BiLSTM with BERT word embeddings to breast cancer forum posts, achieving 79.5% F1-score in detecting seven predefined thematic categories (medication reviews, emotional support, financial concerns). The semi-supervised approach scaled manual annotations to millions of unlabeled posts.

Alhazzani et al. (2023) similarly demonstrated that customized BERT models (PX_BERT) outperform traditional machine learning in patient comment classification. Their 28 classifiers (including BiLSTM, BiGRU, AraBERTv02) achieved high F1-scores, with domain-adapted PX_BERT performing best.

**LDA vs. Deep Learning Trade-offs**:
- **LDA advantages**: Fully unsupervised (no labeled data required), probabilistic interpretation (topic proportions), discovers emergent themes without predefinition
- **Deep Learning advantages**: Higher classification accuracy when labels exist, captures context and word order (BERT), scales to multi-class fine-grained categories
- **Optimal choice**: LDA is ideal for **exploratory research** (discovering unknown dimensions), while deep learning suits **confirmatory classification** (assigning documents to known categories)

**This study employs LDA** for the exploratory reasons outlined above, aligning with recent healthcare review research (Hao & Zhang, 2016; Wallace et al., 2014; Geletta et al., 2019).
```

**æ–°å¢å¼•ç”¨ (2 ç¯‡)**:
11. âœ… Athira et al. (2021) - æ·±åº¦å­¦ä¹ ä¸»é¢˜åˆ†ç±»
12. âœ… Alhazzani et al. (2023) - BERT vs. ä¼ ç»Ÿæ–¹æ³•

---

## ğŸ¯ Priority 3: å¯é€‰è¡¥å……

### æ•´åˆ 6: Section 2.5.4 - Coherence Score éªŒè¯

**æ’å…¥ä½ç½®**: **"1. Statistical Performance Metrics"** å°èŠ‚ï¼Œåœ¨ "**Coherence Score (C_v)**" æ®µè½ä¹‹å

**æ–°å¢å¥å­**:

```markdown
Empirical validations support coherence as a topic quality indicator. Altintas et al. (2021), applying LDA to Reddit cancer forum posts, employed coherence testing to validate that extracted topics exhibited strong internal word co-occurrence, confirming thematic consistency. Their use of t-SNE visualization further revealed inter-topic relationships, demonstrating that coherence scores align with interpretable topic structures.
```

**æ–°å¢å¼•ç”¨ (1 ç¯‡)**:
13. âœ… Altintas et al. (2021) - Coherence éªŒè¯

---

### æ•´åˆ 7: æ–°å¢ References (å®Œæ•´ APA 7th æ ¼å¼)

**åœ¨ "References for Section 2.5" éƒ¨åˆ†æ–°å¢ä»¥ä¸‹å¼•ç”¨**:

```markdown
Alhazzani, N. Z., Al-Turaiki, I. M., & Alkhodair, S. A. (2023). Text classification of patient experience comments in Saudi dialect using deep learning techniques. *Applied Sciences*, 13(18), Article 10305. https://doi.org/10.3390/app131810305

Altintas, V., Albayrak, M., & Topal, K. (2021). Topic modeling with latent Dirichlet allocation for cancer disease posts. *Journal of the Faculty of Engineering and Architecture of Gazi University*, 36(4), 2195-2208. https://doi.org/10.17341/gazimmfd.734730

Athira, B., Jones, J., Idicula, S. M., Kulanthaivel, A., & Zhang, E. (2021). Annotating and detecting topics in social media forum and modelling the annotation to derive directionsâ€”A case study. *Journal of Big Data*, 8, Article 59. https://doi.org/10.1186/s40537-021-00429-7

Danek, S., BÃ¼ttner, M., Krois, J., & Schwendicke, F. (2023). How do users respond to mass vaccination centers? A cross-sectional study using natural language processing on online reviews to explore user experience and satisfaction with COVID-19 vaccination centers. *Vaccines*, 11(1), Article 144. https://doi.org/10.3390/vaccines11010144

Geletta, S., Follett, L., & Laugerman, M. (2019). Latent Dirichlet Allocation in predicting clinical trial terminations. *BMC Medical Informatics and Decision Making*, 19, Article 224. https://doi.org/10.1186/s12911-019-0973-y

Nawab, K., Ramsey, G., & Schreiber, R. (2020). Natural language processing to extract meaningful information from patient experience feedback. *Applied Clinical Informatics*, 11(2), 242-250. https://doi.org/10.1055/s-0040-1708049

Shah, A. M., Yan, X., Tariq, S., & Ali, M. (2021). What patients like or dislike in physicians: Analyzing drivers of patient satisfaction and dissatisfaction using a digital topic modeling approach. *Information Processing & Management*, 58(3), Article 102516. https://doi.org/10.1016/j.ipm.2021.102516

Sun, W., Cai, Z., Li, Y., Liu, F., Fang, S., & Wang, G. (2018). Data processing and text mining technologies on electronic medical records: A review. *Journal of Healthcare Engineering*, 2018, Article 4302425. https://doi.org/10.1155/2018/4302425

van Buchem, M. M., Neve, O. M., Kant, I. M. J., Steyerberg, E. W., Boosman, H., & Hensen, E. F. (2022). Analyzing patient experiences using natural language processing: Development and validation of the artificial intelligence patient reported experience measure (AI-PREM). *BMC Medical Informatics and Decision Making*, 22, Article 199. https://doi.org/10.1186/s12911-022-01923-5

Yazdani, A., Shamloo, M., Khaki, M., & Nahvijou, A. (2023). Use of sentiment analysis for capturing hospitalized cancer patients' experience from free-text comments in the Persian language. *BMC Medical Informatics and Decision Making*, 23, Article 259. https://doi.org/10.1186/s12911-023-02358-2
```

**æ–°å¢å¼•ç”¨æ€»æ•°**: 10 ç¯‡

---

## ğŸ“Š æ•´åˆå‰åå¯¹æ¯”

### ç°æœ‰ Chapter 2.5 å¼•ç”¨æ–‡çŒ®
| # | ä½œè€… | å¹´ä»½ | ç±»å‹ |
|---|------|------|------|
| 1 | Aggarwal & Zhai | 2012 | ä¹¦ç± |
| 2 | Arnold et al. | 2016 | åº”ç”¨ |
| 3 | Blei | 2012 | ç»¼è¿° |
| 4 | Blei et al. | 2003 | LDA åŸå§‹è®ºæ–‡ |
| 5 | Chang et al. | 2009 | æ–¹æ³•è®º |
| 6 | Dagger et al. | 2007 | æœåŠ¡å“è´¨ |
| 7 | Doing-Harris & Zeng-Treitler | 2011 | åº”ç”¨ |
| 8 | Gao et al. | 2012 | åº”ç”¨ |
| 9 | Greaves et al. | 2013 | åº”ç”¨ |
| 10 | Griffiths & Steyvers | 2004 | æ–¹æ³•è®º |
| 11 | Hao & Zhang | 2016 | åº”ç”¨ â­ |
| 12 | Liu | 2012 | æƒ…æ„Ÿåˆ†æ |
| 13 | LÃ³pez et al. | 2012 | åº”ç”¨ |
| 14 | Mimno et al. | 2009 | å¤šè¯­è¨€ |
| 15 | RÃ¶der et al. | 2015 | Coherence |
| 16 | Wallace et al. | 2014 | åº”ç”¨ â­ |
| **æ€»è®¡** | **16 ç¯‡** | **2003-2016** | - |

### æ•´åˆå Chapter 2.5 å¼•ç”¨æ–‡çŒ®
| # | ä½œè€… | å¹´ä»½ | ç±»å‹ |
|---|------|------|------|
| 1-16 | (ä¿ç•™æ‰€æœ‰ç°æœ‰å¼•ç”¨) | 2003-2016 | - |
| **17** | **Sun et al.** | **2018** | **ç»¼è¿°** â­ 21 å¼•ç”¨ |
| **18** | **Geletta et al.** | **2019** | **åº”ç”¨ï¼ˆé¢„æµ‹ï¼‰** |
| **19** | **Nawab et al.** | **2020** | **å®åŠ¡åº”ç”¨** |
| **20** | **Athira et al.** | **2021** | **æ·±åº¦å­¦ä¹ ** |
| **21** | **Altintas et al.** | **2021** | **åº”ç”¨** |
| **22** | **Shah et al.** | **2021** | **åº”ç”¨** â­ |
| **23** | **van Buchem et al.** | **2022** | **ç»¼åˆæ–¹æ³•** â­â­â­ |
| **24** | **Alhazzani et al.** | **2023** | **è·¨è¯­è¨€** â­â­ |
| **25** | **Danek et al.** | **2023** | **å®æ—¶ç›‘æ§** â­ |
| **26** | **Yazdani et al.** | **2023** | **åº”ç”¨** |
| **æ€»è®¡** | **26 ç¯‡** | **2003-2023** | **+10 ç¯‡æ–°æ–‡çŒ®** |

**æ”¹è¿›**:
- âœ… **æ—¶é—´æ›´æ–°**: æœ€æ–°æ–‡çŒ®è‡³ 2023 å¹´ï¼ˆåŸ 2016ï¼‰
- âœ… **æ–‡çŒ®æ•°é‡**: 16 â†’ 26 ç¯‡ï¼ˆ+62.5%ï¼‰
- âœ… **æ–¹æ³•å¤šæ ·æ€§**: æ–°å¢æ·±åº¦å­¦ä¹ ã€æƒ…æ„Ÿåˆ†æã€é¢„æµ‹å»ºæ¨¡
- âœ… **è·¨æ–‡åŒ–æ”¯æŒ**: æ–°å¢é˜¿æ‹‰ä¼¯è¯­ã€æ³¢æ–¯è¯­æ¡ˆä¾‹
- âœ… **é«˜å¼•ç”¨æ–‡çŒ®**: Sun (21 å¼•ç”¨) æä¾›ç»¼è¿°åŸºç¡€

---

## â±ï¸ æ•´åˆå·¥ä½œé‡ä¼°è®¡

### æ—¶é—´åˆ†é…

| ä»»åŠ¡ | é¢„è®¡æ—¶é—´ |
|------|----------|
| **Phase 1: æ ¸å¿ƒæ•´åˆ (Priority 1)** | |
| - Section 2.5.1 è¡¥å…… | 1 å°æ—¶ |
| - Section 2.5.3 è¡¥å…… | 1.5 å°æ—¶ |
| - Section 2.5.5 è¡¥å…… | 1 å°æ—¶ |
| **Phase 2: é‡è¦è¡¥å…… (Priority 2)** | |
| - Section 2.5.1 æ·±åº¦å­¦ä¹ å¯¹æ¯” | 0.5 å°æ—¶ |
| - æƒ…æ„Ÿåˆ†æè¡¥å…… | 0.5 å°æ—¶ |
| **Phase 3: å¯é€‰è¡¥å…… (Priority 3)** | |
| - Section 2.5.4 Coherence éªŒè¯ | 0.5 å°æ—¶ |
| **Phase 4: References æ›´æ–°** | |
| - æ–°å¢ 10 ç¯‡ APA 7th æ ¼å¼å¼•ç”¨ | 0.5 å°æ—¶ |
| - æ£€æŸ¥æ‰€æœ‰å¼•ç”¨æ ¼å¼ä¸€è‡´æ€§ | 0.5 å°æ—¶ |
| **Phase 5: å“è´¨æ£€æŸ¥** | |
| - æ£€æŸ¥è®ºè¿°æµç•…æ€§ | 0.5 å°æ—¶ |
| - éªŒè¯æ‰€æœ‰æ–°å¼•ç”¨æ­£ç¡®æ€§ | 0.5 å°æ—¶ |
| - Cross-reference æ£€æŸ¥ | 0.5 å°æ—¶ |
| **æ€»è®¡** | **7-8 å°æ—¶** |

---

## âœ… æ•´åˆæ£€æŸ¥æ¸…å•

### Phase 1: å‡†å¤‡

- [ ] å¤‡ä»½åŸå§‹ Chapter_2.5_Text_Mining_Topic_Modeling.md
- [ ] åˆ›å»ºæ–°ç‰ˆæœ¬: Chapter_2.5_Text_Mining_Topic_Modeling_REVISED.md
- [ ] ç¡®è®¤æ‰€æœ‰æ–°æ–‡çŒ® DOI æ­£ç¡®

### Phase 2: æ ¸å¿ƒæ•´åˆ (Priority 1)

- [ ] âœ… Section 2.5.1 - æ–°å¢"Recent Methodological Advances"æ®µè½
- [ ] âœ… Section 2.5.3 - æ–°å¢ Geletta (2019), Altintas (2021), Danek (2023)
- [ ] âœ… Section 2.5.3 - ä¿®æ”¹ "Synthesis" æ®µè½
- [ ] âœ… Section 2.5.5 - æ–°å¢"Challenge 4: Cross-Linguistic NLP Validation"

### Phase 3: é‡è¦è¡¥å…… (Priority 2)

- [ ] âœ… Section 2.5.1 - æƒ…æ„Ÿåˆ†æè¡¥å……
- [ ] âœ… Section 2.5.1 - æ·±åº¦å­¦ä¹  vs. LDA å¯¹æ¯”

### Phase 4: å¯é€‰è¡¥å…… (Priority 3)

- [ ] Section 2.5.4 - Coherence éªŒè¯è¡¥å……

### Phase 5: References æ›´æ–°

- [ ] æ–°å¢ 10 ç¯‡å¼•ç”¨ï¼ˆAPA 7th æ ¼å¼ï¼‰
- [ ] æŒ‰å­—æ¯é¡ºåºæ’åˆ—
- [ ] æ£€æŸ¥ DOI é“¾æ¥æœ‰æ•ˆæ€§
- [ ] æ£€æŸ¥ä½œè€…å§“åæ‹¼å†™
- [ ] æ£€æŸ¥æœŸåˆŠåç§°æ­£ç¡®æ€§

### Phase 6: å“è´¨æ£€æŸ¥

- [ ] æ‰€æœ‰æ–°æ®µè½ä¸åŸæ–‡è®ºè¿°é£æ ¼ä¸€è‡´
- [ ] æ‰€æœ‰æ–°å¼•ç”¨åœ¨æ–‡ä¸­æ­£ç¡®æ ‡æ³¨
- [ ] Cross-references æ­£ç¡®ï¼ˆå¦‚ "Section 2.4.4"ï¼‰
- [ ] æœ¯è¯­ä½¿ç”¨ä¸€è‡´ï¼ˆLDA, NLP, EMRï¼‰
- [ ] å­—æ•°æ§åˆ¶ï¼ˆé¿å…è¿‡åº¦å†—é•¿ï¼‰
- [ ] é€»è¾‘è¿è´¯æ€§ï¼ˆæ–°æ®µè½ä¸åŸæ–‡è¡”æ¥è‡ªç„¶ï¼‰

### Phase 7: æœ€ç»ˆéªŒè¯

- [ ] é‡æ–°é˜…è¯»æ•´ä¸ª Section 2.5ï¼Œç¡®ä¿æµç•…
- [ ] æ£€æŸ¥æ˜¯å¦æœ‰é‡å¤è®ºç‚¹
- [ ] ç¡®è®¤æ‰€æœ‰ 10 ç¯‡æ–°æ–‡çŒ®å·²æ•´åˆ
- [ ] åˆ›å»º FINAL_INTEGRATION_SUMMARY.md è®°å½•å˜æ›´

---

## ğŸ¯ æˆåŠŸæŒ‡æ ‡

### æ•°é‡æŒ‡æ ‡

| æŒ‡æ ‡ | åŸç‰ˆ | ç›®æ ‡ | å®Œæˆ |
|------|------|------|------|
| å¼•ç”¨æ–‡çŒ®æ€»æ•° | 16 | 26 | [ ] |
| æœ€æ–°æ–‡çŒ®å¹´ä»½ | 2016 | 2023 | [ ] |
| 2020-2023 æ–‡çŒ® | 0 | â‰¥6 | [ ] |
| è·¨è¯­è¨€æ¡ˆä¾‹ | 0 | â‰¥2 | [ ] |

### å“è´¨æŒ‡æ ‡

- [ ] æ‰€æœ‰æ–°æ–‡çŒ®æ— ç¼æ•´åˆåˆ°åŸæ–‡è®ºè¿°
- [ ] å¼ºåŒ–äº†è·¨æ–‡åŒ–ç ”ç©¶æ–¹æ³•è®ºè®ºè¿°ï¼ˆSection 2.5.5ï¼‰
- [ ] è¡¥å……äº†æ·±åº¦å­¦ä¹  vs. LDA çš„å¯¹æ¯”
- [ ] æ–°å¢äº†å®æ—¶ç›‘æ§ã€é¢„æµ‹å»ºæ¨¡ç­‰æ–°åº”ç”¨
- [ ] æ‰€æœ‰å¼•ç”¨æ ¼å¼ç¬¦åˆ APA 7th edition

---

## ğŸ“ é¢å¤–å»ºè®®

### å¯é€‰æ”¹å†™ï¼ˆå¦‚ Chapter 2.4 æ¨¡å¼ï¼‰

å¦‚æœå¸Œæœ›åƒ Chapter 2.4 ä¸€æ ·è¿›è¡Œå…¨é¢æ”¹å†™ï¼ˆä»æ¡åˆ—å¼æ”¹ä¸ºæµæš¢è«–è¿°ï¼‰ï¼Œå»ºè®®ï¼š

1. **æ£€æŸ¥ç°æœ‰ Chapter 2.5 å†™ä½œé£æ ¼**:
   - ç°æœ‰ Chapter 2.5 **å·²ç»æ˜¯æµæš¢è«–è¿°ä½“**ï¼Œæ— æ¡åˆ—ç‚¹é—®é¢˜
   - **æ— éœ€**åƒ Chapter 2.4 é‚£æ ·å¤§å¹…æ”¹å†™

2. **ä»…éœ€æ•´åˆæ–°æ–‡çŒ®**:
   - æŒ‰æœ¬æŒ‡å—å°† 10 ç¯‡æ–°æ–‡çŒ®æ•´åˆåˆ°ç°æœ‰è®ºè¿°ä¸­
   - ä¿æŒåŸæœ‰å†™ä½œé£æ ¼å’Œé€»è¾‘ç»“æ„

### æœªæ¥æ‰©å±•ï¼ˆå¯é€‰ï¼‰

å¦‚æœå¸Œæœ›è¿›ä¸€æ­¥æ‰©å±• Chapter 2.5ï¼Œå¯è€ƒè™‘ï¼š

1. **æ–°å¢ Section 2.5.7: Recent Trends**
   - è®¨è®º BERT, GPT, Transformer åœ¨åŒ»ç–—æ–‡æœ¬çš„åº”ç”¨
   - å¼•ç”¨ Athira (2021), Alhazzani (2023) ä½œä¸ºæ·±åº¦å­¦ä¹ æ¡ˆä¾‹

2. **æ–°å¢ Table 2.5**:
   - æ¯”è¾ƒ LDA, LSA, NMF, BERT ç­‰æ–¹æ³•
   - åˆ—å‡ºå„æ–¹æ³•ä¼˜ç¼ºç‚¹ã€é€‚ç”¨åœºæ™¯

3. **æ–°å¢ Figure 2.5**:
   - å±•ç¤º LDA å·¥ä½œæµç¨‹å›¾
   - æˆ–å±•ç¤ºæœ¬ç ”ç©¶çš„ Topic Modeling æµç¨‹

---

## ğŸ‰ æ€»ç»“

### æ•´åˆä»·å€¼

1. âœ… **æ–‡çŒ®æ›´æ–°**: ä» 2016 â†’ 2023ï¼Œè¡¥å…… 7 å¹´ç ”ç©¶è¿›å±•
2. âœ… **æ–¹æ³•æ‰©å±•**: æ–°å¢æ·±åº¦å­¦ä¹ ã€æƒ…æ„Ÿåˆ†æã€é¢„æµ‹å»ºæ¨¡
3. âœ… **è·¨æ–‡åŒ–æ”¯æŒ**: æ–°å¢é˜¿æ‹‰ä¼¯è¯­ã€æ³¢æ–¯è¯­æ¡ˆä¾‹ï¼Œå¼ºåŒ– Section 2.5.5
4. âœ… **åº”ç”¨æ‹“å±•**: ä»è¯„è®ºåˆ†æ â†’ å®æ—¶ç›‘æ§ã€é¢„æµ‹ã€æ”¿ç­–åº”ç”¨
5. âœ… **é«˜å“è´¨æ–‡çŒ®**: åŒ…å«é«˜å¼•ç”¨ç»¼è¿°ï¼ˆSun 21 å¼•ç”¨ï¼‰å’Œé¡¶çº§æœŸåˆŠï¼ˆBMC Med Informï¼‰

### ä¸‹ä¸€æ­¥

1. **ç«‹å³è¡ŒåŠ¨**: æŒ‰ Priority 1 å¼€å§‹æ•´åˆ 3 ç¯‡æ ¸å¿ƒæ–‡çŒ®
2. **å“è´¨ä¿è¯**: æ•´åˆåé‡æ–°é˜…è¯» Section 2.5 å…¨æ–‡
3. **åˆ›å»ºæ€»ç»“**: å®Œæˆååˆ›å»º FINAL_INTEGRATION_SUMMARY.md

---

**æ•´åˆæŒ‡å—å®Œæˆæ—¥æœŸ**: 2025-11-06
**é¢„è®¡æ•´åˆæ—¶é—´**: 7-8 å°æ—¶
**å»ºè®®æ•´åˆé¡ºåº**: Priority 1 â†’ Priority 2 â†’ Priority 3
